Name | Sales (Cr) | Profit (Cr) | EBITDA (Cr) | Financial Year |
---|---|---|---|---|
ICRA | 446.11 | 152.24 | 223.73 | MAR, 2024 |
CARE Ratings | 331.68 | 102.56 | 158.82 | MAR, 2024 |
CRISIL | 3,139.52 | 658.44 | 975.14 | DEC, 2023 |
Company | Market Cap (Cr) | Chg (%) | PE (x) | PB (x) | EV to Sales (x) | EV to EBITDA (x) | Dividend Yield (%) |
---|---|---|---|---|---|---|---|
CRISIL | 38,542.98 | 6.08 | 57.57 | 18.19 | 12.17 | 42.67 | 1.02 |
ICRA | 5,963.40 | 0.03 | 39.43 | 6.26 | 13.06 | 39.93 | 1.62 |
CARE Ratings | 4,036.78 | 1.40 | 35.30 | 5.41 | 12.02 | 35.85 | 1.33 |